<DOC>
	<DOC>NCT01394445</DOC>
	<brief_summary>The investigators hypothesize that the administration of physostigmine in the postoperative period after nephrectomy reduces opioid consumption.</brief_summary>
	<brief_title>Pilot Study of Physostigmine-Enhanced Opioid Analgesia</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Physostigmine</mesh_term>
	<criteria>At least 18 years old At least 50 kg Suitable for PCA ASA 13 Bronchial asthma/severe or exacerbated COPD Iritis Stenoses/spasms of intestine, urinary tract, biliary tract Closed traumatic brain injury Severely reduced left ventricular function (EF&lt;30%) Recent myocardial infarction Recent stroke Known allergy or hypersensitivity or contraindications against hydromorphone, physostigmine History of alcohol or drug abuse Patients enrolled in another study Women of childbearing age without a negative pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>